Sequana Medical NV
SQNMF
$1.22
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -90.86% | -85.19% | -64.88% | -46.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -90.86% | -85.19% | -64.88% | -46.69% |
| Cost of Revenue | -99.64% | -90.02% | -83.89% | -63.36% | -44.53% |
| Gross Profit | -100.11% | -91.13% | -85.59% | -65.36% | -47.34% |
| SG&A Expenses | -21.23% | -29.36% | -34.19% | -27.31% | -20.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -32.14% | 36.49% | 38,425.00% | 12,840.00% | 3,762.90% |
| Total Operating Expenses | -25.01% | -32.69% | -37.22% | -29.04% | -20.75% |
| Operating Income | 23.64% | 31.44% | 36.07% | 28.12% | 20.05% |
| Income Before Tax | -93.16% | -61.59% | -38.34% | -13.25% | 13.43% |
| Income Tax Expenses | -26.30% | -34.78% | -39.76% | -24.44% | -5.36% |
| Earnings from Continuing Operations | -91.60% | -60.27% | -37.23% | -12.75% | 13.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -91.60% | -60.27% | -37.23% | -12.75% | 13.34% |
| EBIT | 23.64% | 31.44% | 36.07% | 28.12% | 20.05% |
| EBITDA | 25.66% | 32.45% | 36.32% | 28.39% | 20.32% |
| EPS Basic | -28.09% | -8.12% | 5.04% | 16.94% | 28.56% |
| Normalized Basic EPS | -29.14% | -9.00% | 4.29% | 16.63% | 28.64% |
| EPS Diluted | -28.09% | -8.12% | 5.04% | 16.94% | 28.56% |
| Normalized Diluted EPS | -29.14% | -9.00% | 4.29% | 16.63% | 28.64% |
| Average Basic Shares Outstanding | 54.42% | 46.37% | 37.26% | 30.67% | 23.48% |
| Average Diluted Shares Outstanding | 54.42% | 46.37% | 37.26% | 30.67% | 23.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |